Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000411801 | SCV000488675 | likely benign | Paragangliomas 5 | 2016-05-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000443248 | SCV000520350 | likely benign | not specified | 2018-01-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Institute for Clinical Genetics, |
RCV001528662 | SCV002009956 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002058842 | SCV002440955 | benign | Mitochondrial complex II deficiency, nuclear type 1; Paragangliomas 5 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003168597 | SCV003901075 | benign | Hereditary cancer-predisposing syndrome | 2023-03-01 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
KCCC/NGS Laboratory, |
RCV000411801 | SCV004015407 | likely benign | Paragangliomas 5 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000411801 | SCV004018605 | likely benign | Paragangliomas 5 | 2023-04-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. |
ARUP Laboratories, |
RCV001528662 | SCV004564869 | likely benign | not provided | 2023-10-13 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001528662 | SCV001740787 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001528662 | SCV001808497 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001528662 | SCV001958811 | likely benign | not provided | no assertion criteria provided | clinical testing |